MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, ISCO has $5,133K in assets. $5,049K in debts.

Balance Sheets Overview

Current Ratio
75.52%
Quick Ratio
40.40%
Debt to Asset Ratio
98.36%
Unit: Thousand (K) dollars
Assets Breakdown
    • Less accumulated depreciation an...
    • Inventories
    • Cash
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Series d redeemable convertible ...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash
933 993 966 920
Accounts receivable, net
791 723 1,015 1,101
Inventories
1,773 1,514 1,591 1,550
Prepaid expenses and other current assets
316 181 162 269
Total current assets
3,813 3,411 3,734 3,840
Non-current inventories
226 229 239 266
Property and equipment, gross
2,635 2,614 2,622 -
Less accumulated depreciation and amortization
2,466 2,454 2,430 -
Property and equipment, net
169 160 192 225
Intangible assets, net
633 644 661 681
Right-of-use assets
261 344 425 504
Deposits and other assets
31 31 31 31
Total assets
5,133 4,819 5,282 5,547
Accounts payable
437 168 265 397
Accrued liabilities
842 428 452 651
Operating lease liabilities, current
297 393 383 371
Advances
250 250 250 250
Related party note payable
3,223 3,340 3,305 3,270
Total current liabilities
5,049 4,579 4,655 4,939
Operating lease liabilities, net of current portion
0 -103 204
Total liabilities
5,049 4,579 4,758 5,143
Series d redeemable convertible preferred stock, 0.001 par value 50 shares authorized 43 shares issued and outstanding liquidation preference of 4,300 at march 31,2026 and december 31, 2025
4,300 4,300 4,300 4,300
Non-redeemable convertible preferred stock, 0.001 par value 10,004,310 and 10,004,310 shares authorized 5,254,310 and 5,254,310 shares issued and outstanding liquidation preference of 9,830 and 9,826 at march 31, 2026 and december 31, 2025, respectively
5 5 5 5
Common stock, 0.001 par value 120,000,000 shares authorized 8,004,389 shares issued and outstanding at march 31, 2026 and december 31, 2025
8 8 8 8
Additional paid-in capital
107,094 107,030 106,966 106,903
Accumulated deficit
-111,323 -111,103 -110,755 -110,812
Total stockholders' deficit
-4,216 -4,060 -3,776 -3,896
Total liabilities, redeemable convertible preferred stock and stockholders' deficit
5,133 4,819 5,282 5,547
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Inventories$1,773K Cash$933K Accounts receivable, net$791K Prepaid expenses andother current assets$316K Property and equipment,gross$2,635K Total current assets$3,813K Intangible assets, net$633K Right-of-use assets$261K Non-current inventories$226K Property and equipment,net$169K Deposits and other assets$31K Less accumulateddepreciation and...$2,466K Total assets$5,133K Accumulated deficit-$111,323K Total liabilities,redeemable convertible...$5,133K Total stockholders'deficit-$4,216K Additional paid-in capital$107,094K Common stock, 0.001 parvalue 120,000,000...$8K Non-redeemable convertiblepreferred stock, 0.001 par...$5K Total liabilities$5,049K Series d redeemableconvertible preferred...$4,300K Total currentliabilities$5,049K Related party notepayable$3,223K Accrued liabilities$842K Accounts payable$437K Operating leaseliabilities, current$297K Advances$250K

International Stem Cell CORP (ISCO)

International Stem Cell CORP (ISCO)